AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 94 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,551 | -35.5% | 5,347,689 | 0.0% | 0.19% | -27.9% |
| Q4 2022 | $2,406 | -99.9% | 5,347,689 | 0.0% | 0.27% | -19.9% |
| Q3 2022 | $2,813,000 | +4.1% | 5,347,689 | 0.0% | 0.34% | +6.0% |
| Q2 2022 | $2,701,000 | -58.8% | 5,347,689 | +87.8% | 0.32% | -50.2% |
| Q1 2022 | $6,550,000 | -51.6% | 2,847,689 | 0.0% | 0.64% | -40.7% |
| Q4 2021 | $13,527,000 | -40.2% | 2,847,689 | 0.0% | 1.07% | -23.6% |
| Q3 2021 | $22,639,000 | +20.5% | 2,847,689 | +5.5% | 1.40% | +14.1% |
| Q2 2021 | $18,792,000 | -12.1% | 2,700,000 | 0.0% | 1.23% | +1.7% |
| Q1 2021 | $21,384,000 | +0.6% | 2,700,000 | 0.0% | 1.21% | -9.2% |
| Q4 2020 | $21,249,000 | +11.0% | 2,700,000 | 0.0% | 1.33% | -25.2% |
| Q3 2020 | $19,143,000 | -23.4% | 2,700,000 | 0.0% | 1.78% | -31.8% |
| Q2 2020 | $24,975,000 | – | 2,700,000 | – | 2.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |